ResMed Inc.
RMD
$219.72
-$0.50-0.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.26% | 11.08% | 9.01% | 7.17% | 12.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.26% | 11.08% | 9.01% | 7.17% | 12.48% |
| Cost of Revenue | 3.07% | 1.27% | 0.69% | 1.13% | 13.63% |
| Gross Profit | 15.83% | 19.04% | 15.62% | 11.90% | 11.61% |
| SG&A Expenses | 8.76% | 7.23% | 0.62% | 0.64% | 4.95% |
| Depreciation & Amortization | -5.81% | -10.81% | -7.07% | -7.28% | 17.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.02% | 2.94% | 0.74% | 0.76% | 10.51% |
| Operating Income | 22.96% | 34.02% | 33.18% | 24.58% | 17.57% |
| Income Before Tax | 61.23% | 40.89% | 29.24% | 29.73% | -5.20% |
| Income Tax Expenses | 45.50% | 36.71% | 38.95% | 31.74% | 3.85% |
| Earnings from Continuing Operations | 65.05% | 41.90% | 27.25% | 29.24% | -7.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.05% | 41.90% | 27.25% | 29.24% | -7.16% |
| EBIT | 22.96% | 34.02% | 33.18% | 24.58% | 17.57% |
| EBITDA | 21.24% | 30.17% | 28.26% | 21.66% | 17.72% |
| EPS Basic | 65.41% | 42.11% | 27.33% | 29.20% | -7.44% |
| Normalized Basic EPS | 29.21% | 41.05% | 38.77% | 27.71% | 18.59% |
| EPS Diluted | 64.89% | 41.61% | 26.89% | 29.11% | -7.25% |
| Normalized Diluted EPS | 28.99% | 40.73% | 38.68% | 27.71% | 18.83% |
| Average Basic Shares Outstanding | -0.22% | -0.15% | -0.07% | 0.03% | 0.29% |
| Average Diluted Shares Outstanding | -0.04% | 0.08% | -0.01% | 0.04% | 0.09% |
| Dividend Per Share | 10.42% | 10.42% | 9.09% | 9.09% | 9.09% |
| Payout Ratio | -0.33% | -0.22% | -0.14% | -0.16% | 0.18% |
